Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. [electronic resource]
- The Journal of biological chemistry Apr 2002
- 12144-50 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0021-9258
10.1074/jbc.M200102200 doi
Animals B-Lymphocytes--metabolism Benzoquinones Butadienes--pharmacology Cell Division Cells, Cultured Cyclin D2 Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinases--metabolism Cyclins--biosynthesis Enzyme Activation Enzyme Inhibitors--pharmacology Flavonoids--pharmacology HSP90 Heat-Shock Proteins--metabolism Immunoblotting Lactams, Macrocyclic MAP Kinase Kinase 1 MAP Kinase Kinase 2 Mice Mice, Inbred BALB C Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinase Kinases--metabolism Mitogen-Activated Protein Kinases--metabolism Models, Biological Nitriles--pharmacology Phosphatidylinositol 3-Kinases--metabolism Phosphorylation Precipitin Tests Protein Binding Protein Kinase C--metabolism Protein Serine-Threonine Kinases--metabolism Protein-Tyrosine Kinases--metabolism Proto-Oncogene Proteins Quinones--pharmacology RNA--metabolism RNA, Messenger--metabolism Receptors, Antigen, B-Cell--metabolism Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Spleen--metabolism